These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33462277)

  • 21. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
    He Y; Su Z; Xue L; Xu H; Zhang C
    J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A tumor-targeting near-infrared laser-triggered drug delivery system based on GO@Ag nanoparticles for chemo-photothermal therapy and X-ray imaging.
    Shi J; Wang L; Zhang J; Ma R; Gao J; Liu Y; Zhang C; Zhang Z
    Biomaterials; 2014 Jul; 35(22):5847-61. PubMed ID: 24746963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultra pH-sensitive polymeric nanovesicles co-deliver doxorubicin and navitoclax for synergetic therapy of endometrial carcinoma.
    Ding J; Zhang X; Chen C; Huang Y; Yu X; Li X
    Biomater Sci; 2020 Apr; 8(8):2264-2273. PubMed ID: 32134074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel intracellular pH-responsive formulation for FTY720 based on PEGylated graphene oxide nano-sheets.
    Masoudipour E; Kashanian S; Maleki N; Karamyan A; Omidfar K
    Drug Dev Ind Pharm; 2018 Jan; 44(1):99-108. PubMed ID: 28956455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and in vitro and in vivo evaluations of poly(ethylene glycol)-block-poly(4-vinylbenzylphosphonate) magnetic nanoparticles containing doxorubicin as a potential targeted drug delivery system.
    Hałupka-Bryl M; Asai K; Thangavel S; Bednarowicz M; Krzyminiewski R; Nagasaki Y
    Colloids Surf B Biointerfaces; 2014 Jun; 118():140-7. PubMed ID: 24769390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation.
    Qiu X; Cao K; Lin T; Chen W; Yuan A; Wu J; Hu Y; Guo H
    Int J Nanomedicine; 2017; 12():7365-7374. PubMed ID: 29066888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Folate-containing reduction-sensitive lipid-polymer hybrid nanoparticles for targeted delivery of doxorubicin.
    Wu B; Yu P; Cui C; Wu M; Zhang Y; Liu L; Wang CX; Zhuo RX; Huang SW
    Biomater Sci; 2015 Apr; 3(4):655-64. PubMed ID: 26222425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epithelial cell adhesion molecule aptamer conjugated PEG-PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro.
    Alibolandi M; Ramezani M; Sadeghi F; Abnous K; Hadizadeh F
    Int J Pharm; 2015 Feb; 479(1):241-51. PubMed ID: 25529433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel delivery system of doxorubicin with high load and pH-responsive release from the nanoparticles of poly (α,β-aspartic acid) derivative.
    Wang X; Wu G; Lu C; Zhao W; Wang Y; Fan Y; Gao H; Ma J
    Eur J Pharm Sci; 2012 Aug; 47(1):256-64. PubMed ID: 22522116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery.
    Elbialy NS; Fathy MM; Khalil WM
    Int J Pharm; 2015 Jul; 490(1-2):190-9. PubMed ID: 25997662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Charge-conversional PEG-polypeptide polyionic complex nanoparticles from simple blending of a pair of oppositely charged block copolymers as an intelligent vehicle for efficient antitumor drug delivery.
    Lv S; Song W; Tang Z; Li M; Yu H; Hong H; Chen X
    Mol Pharm; 2014 May; 11(5):1562-74. PubMed ID: 24606535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. pH-responsive graphene oxide loaded with targeted peptide and anticancer drug for OSCC therapy.
    Li R; Gao R; Zhao Y; Zhang F; Wang X; Li B; Wang L; Ma L; Du J
    Front Oncol; 2022; 12():930920. PubMed ID: 35992794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoparticles generated by PEG-Chrysin conjugates for efficient anticancer drug delivery.
    Zheng H; Li S; Pu Y; Lai Y; He B; Gu Z
    Eur J Pharm Biopharm; 2014 Aug; 87(3):454-60. PubMed ID: 24691159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. pH and near-infrared light dual-stimuli responsive drug delivery using DNA-conjugated gold nanorods for effective treatment of multidrug resistant cancer cells.
    Zhang W; Wang F; Wang Y; Wang J; Yu Y; Guo S; Chen R; Zhou D
    J Control Release; 2016 Jun; 232():9-19. PubMed ID: 27072026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor Acidity/NIR Controlled Interaction of Transformable Nanoparticle with Biological Systems for Cancer Therapy.
    Li D; Ma Y; Du J; Tao W; Du X; Yang X; Wang J
    Nano Lett; 2017 May; 17(5):2871-2878. PubMed ID: 28375632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging Dendrimer-Grafted Graphene Oxide Mediated Anti-miR-21 Delivery With an Activatable Luciferase Reporter.
    Wang F; Zhang B; Zhou L; Shi Y; Li Z; Xia Y; Tian J
    ACS Appl Mater Interfaces; 2016 Apr; 8(14):9014-21. PubMed ID: 27010367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.
    Zhang X; Li J; Yan M
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1590-9. PubMed ID: 26942448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
    Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS
    Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual Drugs Anticancer Nanoformulation using Graphene Oxide-PEG as Nanocarrier for Protocatechuic Acid and Chlorogenic Acid.
    Bullo S; Buskaran K; Baby R; Dorniani D; Fakurazi S; Hussein MZ
    Pharm Res; 2019 Apr; 36(6):91. PubMed ID: 31020429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
    Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD
    Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.